Antiphospholipid antibody syndrome;Antiphospholipidantikorpersyndrom

Medizinische Klinik

Volumn 94, Issue 2, 1999, Pages 93-100

  Schmidt, Rüdiger ^a   Scheuermann, Ernst Heinrich ^b   Viertel, Achim ^b   Geiger, Helmut ^b   Scharrer, Inge ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Universitätskliniken ^*

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Lupus anticoagulant

Indexed keywords

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; BUDD CHIARI SYNDROME; CHOREA; CLINICAL FEATURE; FETUS WASTAGE; HEMOLYTIC ANEMIA; HUMAN; HYPERTENSION; IMMUNOTHERAPY; INTRAUTERINE GROWTH RETARDATION; LIVEDO RETICULARIS; MIGRAINE; PREECLAMPSIA; REVIEW; THROMBOCYTOPENIA; THROMBOSIS; VALVULAR HEART DISEASE; BLOOD; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY;

PHOSPHOLIPID ANTIBODY;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 0033556835     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044707     Document Type: Review

References (120)

1. Alarcon-Segovia D, Deleze M, Oria CV, et al. Anti-phospholipid antibodies and the anti-phospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 5000 consecutive patients. Medicine (Baltimore) 1989;68:353-65.
2. Ames PR, Pyke S, Iannaccone L. et al. et al. Antiphospholipid antibodies, haemostatic variables and thrombosis - a survey of 144 patients. Thromb Haemost 1995;73:768-73.
3. Asherson RA, Oakley C. Pulmonary hypertension in SLE. J Rheumatol 1986;1:1-5.
4. Asherson RA, Mercy D, Phillips G, et al. Recurrent stroke and multi-infarct dementia in SLE associated with antiphospho-lipid antibodies. Ann Rheum Dis. 46 (1987), 605-611.
5. Asherson, R.A., E.N. Harris, A.E. Gharavi, G.R.V. Hughes: Anticardiolipin antibody, recurrent thrombosis and warfarin withdrawel. Ann Rheum Dis 1985;44:823-5.
6. Asherson RA, Liote F, Page B. Aseptic necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1993;29:284-8.
7. Asherson RA, Hughes GRV. Antiphospholipid antibodies and chorea. J Rheumatol 1988;15;377-9.
8. Asherson RA, Kant KS. Antiphospholipid antibodies and the kidney. J Rheumatol 1993;28:1268-72.
9. Asherson RA, Khamashta MA, Baguley E, et al. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. QJ Med 1989;73:11103-5.
10. Asherson RA, Khamashta MA, Ordi-Ros J, R et al. The primary antiphospho-hpid-syndrome: Major clinical and serological features. Medicine (Baltimore) 1989;68:366-74.
11. Asherson RA, Mayou SC, Merry P, et al. The spectrum of livedo reticularis and anticardiolipin antibodies. Br J Dermatol 1989;120:212-5.
12. Averbach M, Levo Y. Budd-Chiari syndrome as the major thrombotic complication of systemic lupus erythematosus with lupus anticoagulant. Ann Rheum Dis 1986;45:435-7.
13. Badui E, Garcia-Rubi D, Robles E, et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985;36:431-41.
14. Balasch J, Carmona F. Lopez-Soto A, et al. Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod 1998;8:2234-9.
15. Banfi G, Bertani T, Boeri V, et al. for the Gruppo Italia-no per lo Studio della Nefrite Lupica (GISNEL). Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis 1991;58:240-8.
16. Bick RL, Baker WF. Antiphospholipid and thrombosis syndromes. Semin Thromb Hemostas 1994;20:3-15.
17. Bick RL. The antiphospholipid-thromhosis syndromes. Fact, fiction, confusion, and controvesy. Am J Clin Pathol 1993;100:477-80.
18. Bowie EJW, Thompson JH, Pascuzzi CA, et al. Thrombosis in systemic lupus erythematodes despite circulating anticoagulant. J Lab Clin Med 1963;62:416-30.
19. Branch DW, Andres R, Digre KB, et al. The association of anti-phospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989;73:541-5.
20. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1945;74:1185-90.
21. Briley DP, Coull BM, Goodnight SH. Neurologic disease associated with antiphospholipid antibodies. Ann Neurol 1989;25:221-7.
22. Brown JH, Doherty CC, Allen DC, et al. Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus. Br Med J 1988;296:1505.
23. Brunet P. Aillaud MF, San-Marco M, et al. Antiphospholipids in hemodialysis patients: relationship between lupus anticoagulant and thrombosis. Kidney Int 1995;48:794-800.
24. Buchanan NMM. Khamashta MA, Morton KE, et al. A study of 100 high risk lupus pregnancies. Am J Reprod Immunol 1992;28:192-4.
25. Burrow JN. Blumbergs PC, Iyer PV, et al. Kohlmeier-Degos disease: a multisystem vasculopathy with progressive cerebral infarction. Aust NZJ Med 1991;21:49-51.
26. Canoso RT, deOliveira RM. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant. Absense of thrombosis. Am J Hematol 1988;27:272-5.
27. Carette S. Jobin F. Acute adrenal insufficiancy as a manifestation of the anticardiolipin syndrome? Ann Rheum Dis 1989;48:430-1.
28. Carreras LO, Vermylen J, Spitz B. Lupus anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 1981;88: 890-4.
29. Cervera R, Khamashta MA, Font J, et al. and the European Working Party on Systemic Lupus Erythematosus: Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore) 1993;72:113-24.
30. Chartash EK, Lans DM, Paget SA, et al. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 1989;86:407-12.
31. Chedid A, Chadalawada KR, Morgan TR, et al. Phospholipid antibodies in alcoholic liver disease. Hepatology 1994;20:1465-71.
32. Conley CL, Hartman RC. Haemorrhagic disorder caused by circulating anticoagulant in patients with dissiminated lupus erythematosus. J Clin Invest 1952;31:621-2.
33. Cowchock FS, Reece EA. Balaban D, et al. Repeated fetal loss associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisolone to low dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-23.
34. Cox NH, Long E. Dowling-Degos disease and Kitamura's reticulate acropigmentation: support for the concept of a single disease. Br J Dermatol 1991;125:169-71.
35. D'Alton JG, Preston DN, Bormanis J. Multiple transient ischaemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 1985;16:512-4.
36. de-la-Mata J. Gomez-Sanchez MA, Aranzana M, et al. Long-term iloprost infusion therapy tor severe pulmonary hypertension in patients with connective tissue diseases. Arthritis Rheum 1994;37:1528-33.
37. Exner T. Diagnostic methodologies for circulating anticoagulants. Thromb Haemost 1995;74:338-44.
38. Fabris F, Steffan A, Cordiano I, et al. Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia. Eur J Haematol 1994;53:232-6.
39. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972;1:75-95.
40. Fields RA, Toubbeh H, Searles RP, et al. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989;16:623-5.
41. Fox B. Venous infarction of the adrenal glands. J Pathol 1976;15:65-87.
42. Frick PG. Acquired circulating anticoagulants in systemic "collagen disease". Blood 1955;10:691-706.
43. Gabrielli F, Alcini E, Di-Prima MA, et al. Cardiac valve involve-ment in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol 1995;51:117-26.
44. Galli M, Bevers EM. Inhibition of phospholipid-dependent coagulation reactions by antiphospholipid antibodies: possible mechanisms of action. Lupus 1994;3:223-8.
45. Galve E, Ordi J, Barquinero J, et al. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med 1992;116:293-8.
46. Ghosh S, Walters HD, Joist JH, et al. Adult respiratory distress syndrome associated with antiphospholipid antibody syndrome. J Rheumatol 1993;20:1406-8.
47. Ginsberg JS, Wells PS. Brill-Edwards P, et al. Antiphosphohpid antibodies and venous thromboembolism. Blood 1995;86:3685-91.
48. Goldberg SN, Conti-Kelly AM, Greco TP. A family study of anticardiolipin antibodies and associated clinical conditions. Am J Med 1995;99:473-9.
49. Gorman DG, Cunnnings JL. Neurobehavioral presentations of the antiphospholipid antibody syndrome. J Neuropsychiat Clin Neurosci 1993;5:37-42.
50. Grattan CE, Burton JL. Antiphospholipid syndrome and cutaneous vasoocclusive disorders. Semin Dermatol 1991;10:152-9.
51. Greisman SG. Thayaparan RS, Godwin TA, et al. Occlusiv vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody. Arch Intern Med 1991;1521:389-92.
52. Guanieri M, Eisner D. A DNA antigen that reacts with antisera to cardiolipin. Biochem Biophys Res Commun 1974;58:347-53.
53. Hamsten A, Norberg R, Björkholm M, et al. Antibodies to cardiohpin in young survivors of myocardial infarction. Lancet 1986;1:113-6.
54. Harris EN, Chan JKH, Asherson RA. Thrombosis, recurrent fetal loss, and thrombocytopenia: Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986;146:2153-6.
55. Harris EN, Gharavi AE, Asherson RA. Thrombocytopenia in SLE and related autoimmun disorders: Association with anticardiolipin antibody. Br J Haematol 1985;59:227-30.
56. Hochfeld M, Druzin M, Maia D, et al. Pregnancy complicated by primary antiphospholipid antibody syndrome. Obstet Gynecol 1994;83:804-5.
57. Homans DC. Peripartum cardiomyopathy. N Engl J Med 1985;312:1432-7.
58. Hughes GRV. The antiphospholipid syndrome. Lupus 1990;5:345-6.
59. Kattwinkel N, Villanueva AG, Labib SB, et al. Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid syndrome. Ann Intern Med 1992;116:974-6.
60. Khamashta MA, Hughes GRH. Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol 1995;7:389-94.
61. Khamastha MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.
62. Kniaz D, Eisenberg GM, Elrad H, et al. Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies. Am J Nephrol 1992;12:126-33.
63. Le-Thi-Huong D, Wechsler B, Edelman P, et al. Postpartum cerebral infarction associated with aspirin withdrawal in the antiphospholipid antibody syndrome. J Rheumatol 1993;20:1229-32.
64. Levine, SR, Brey RL, Joseph CLM, et al. on behalf of the Antiphospholipid Antibodies in Stroke Study Group: Risk of thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke 1992;23:Suppl 1:29-32.
65. Lockshin MD, Druzin ML, Goei S, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152-6.
66. Lockshin MD. Which patients with antiphospholipid antibody should be treated and how? Rheum Dis Clin North Am 1993;19:235-47.
67. Lockwood CJ, Romero R, Feinberg RF, et al. The prevalence and significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetic population. Am J Obstet Gynecol 1989;161:369-73.
68. Mackworth-Young CG, Loizou S, Walport MJ. Primary antiphospholipid-syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989;48:362-7.
69. Mackworth-Young CG, Melia WM, Harris E, et al. The Budd-Chiari syndrome. Possible pathogenetic role of antiphospholipid antibodies. J Hepatol 1986;3:83-6.
70. Mandreoli M, Zucchelli P. Renal vascular diseasea in patients with primary antiphospholipid antibodies. Nephrol Dial Transplant 1993;8:1277-80.
71. Manoussakis MN, Tzioufas AG, Silis MP. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987;69:557-65.
72. Matsuda J, Saitoh N, Gotoh M, et al. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha. Am J Gastroenterol 1995;90:1138-41.
73. Mazzucchelli R, Barbadillo C, Yousset H, et al. Catastrophic antiphospholipid syndrome: a rare manifestation of the antiphospholipid antibody syndrome. Clin Exp Rheumatol 1993;11:637-57.
74. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991;49:193-280.
75. McNeil HP, Gravaghan TP, Krilis SA, et al. HLA-DR antigens and anticardiolipin antibodies. Clin Exp Rheuniatol 1990;8:425-6
76. Migliaresi S, Picillo U, Ambrosone L, et al. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994;3:37-41.
77. Miranda JM, Garcia-Torres R, Jara LJ, et al. Renal biopsy in systemic lupus erythematosus. Analysis of 108 cases. Lupus 1994;3:25-9.
78. Mondragon-Ramirez G, Bochicchio T, Garcia-Torres R, et al. Recurrent renal thrombotic angiopathy after kidney transplantation in two patients with primary antiphospholipid syndrome (PAPS). Clin Transplant 1994;8:93-6.
79. Montalban J, Codina A, Ordi J, et al. Antiphospholipid antibodies in cerebral ischaemia. Stroke 1991;22:751-3.
80. Moore JE, Mohr CF. Biologically false positive serologic tests for syphilis. JAMA 1952;150:467-73.
81. Morton KE, Gavahan TP, Kirilis SA. Coronary artery bypass graft failure: An autoimmune phenomenon? Lancet 1986;2:1353-6.
82. Mtujic F, Cuadrado MJ, Lloyd M, et al. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J Rheumatol 1995;22:1589-92.
83. Müller JF, Ratnoff O, Heinle RW. Observations on the characteristics of an unusual circulating anticoagulant. J Lab Clin Med 1951;38:254-61.
84. Naldi L, Locati F, Marchesi L, et al. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis 1993;52:219-22.
85. Nickele GA, Foster PA, Kenny D. Primary antiphospholipid syndrome and mitral valve thrombosis. Am Heart J 1994;128:1245-7.
86. Nihoyannopoulos P, Gomez PM, Joshi J, et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 1990;82:369-75.
87. O'Hickey S, Skinner C, Beattie J. Life-threatening right ventricular thrombosis in association with phospholipid antibodies. Br Heart J 1993;70:279-81.
88. Ornstein MH, Rand JH. An association between refractory HELLP-syndrome and antiphospholipid antibodies during pregnancy: a report of 2 cases. J Rheumatol 1994;21:1360-4.
89. Out HJ, Brumse HW, Christiaens GC, et al. A prospective, controlled multicenter study on the obstetic risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992;167:26-32.
90. Pangborn MC. A new serologically active phopholipid from beef heart. Proc Soc Exp Biol Med 1941;48:484-6.
91. Peacock NW, Levine SP. Case report: The lupus anticoagulant-hypoprothrombinemia syndrome. Am J Med Sci 1994;307:346-9.
92. Pelletier S, Landi B, Piette JC. The antiphospholipid syndrome as the second cause of non-malignant Budd-Chiari syndrome. Arthritis Rheum 1992;35:S 238.
93. Perez RE, McClendon JR. Primary antiphospholipid syndrom with multiorgan arterial and venous thrombosis. J Rheumatol 1992;19:1289-92.
94. Perez-Vasquez ME, Cabiedes J, Cabral AR, et al. Decrease in serum antiphospholipid antibody levels upon developement of nephrotic syndrome in patients with systemic lupus erythenutosus: relationship to urinary loss of IgG and other factors. Am J Med 1992;92:357-62.
95. Piette JC, Cacoub P, Wechsler B. Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 1994;23:357-66.
96. Polzin WJ, Kopelman JN, Robinson RD, et al. The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction. Obstet Gynecol 1991;78:1108-11.
97. Pope JM, Canny CL, Bell DA. Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant. Am J Med 1991;90:299-309.
98. Quereda C, Otero GG, Pardo A, et al. Prevalence of antiphospholipid antibodies in nephropathies not due to systemic lupus erythematosus. Am J Kidney Dis 1994;23:555-61.
99. Radhakrishnan J, Williams GS, Appel GB, et al. Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients. Am J Kidney Dis 1994;23:286-9.
100. Rivier G, Herranz MT, Kamashta MA, et al. Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments. Lupus 1995;3:85-90.
101. Rosner E, Pauzner R, Lusky A, et al. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987;57:144-7.
102. Rosove MH, Harris EN, Gharavi AE, et al. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-8.
103. Sanchez-Guerrero J, Reves E, Alarcon-Segovia D. Primary antiphospholipid syndrome as cause of intestinal infarction. J Rheumatol 1992;19:623-5.
104. Scharrer I. Diagnostik und Bedeutung der Lupus-Antikoagulantien. In: Keller F. Hrsg. Neue Aspekte der Hämostaseologie. Xxxxx: Medizinische Verlagsgesellschaft, 1996:72-8.
105. Silver RK, MacGregor SN, Sholl JS, et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993;169:1411-7.
106. Sturfelt G, Eskilsson J. Nived O, et al. Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients from a defined population. Medicine (Baltimore) 1992;71:216-23.
107. Syrjanen J, Vaarala O, Iivanainen M. Anticardiolipin response and its association with infections in young and middle aged patients with cerebral infarction. Acta Neurol Scand 1988;78:381-6.
108. Tabbutt S, Griswold WR, Ogino MT, et al. Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. Perinatology 1994;14:66-70.
109. Tada K, Akamatsu K. Konno T, et al. Clinical significance of antiphospholipid antibodies in fulminant hepatic failure. Hepatogastroenterology 1995;42:27-30.
110. Thiagarajan P, Shapiro SS, DeMarco L. A monoclonal IgM coagulation inhibitor with phospholipid specificity: Mechanism of a lupus anticoagulant. J Clin Invest 1980;66:397-405.
111. Toren P, Toren A, Weizman A, et al. Tourette's disorder: is there an association with the antiphospholipid syndrome? Biol Psychiat 1994;35:495-8.
112. Triplett DA. Protean clinical presentation of antiphospholipid-protein-antibodies (APA). Thromb Haemostas 1995;74:329-37.
113. Vaarala O, Vaara M, Palosua T. Effective inhibition of cardiolipin-binding antibodiesin gram-negative infection by bacterial lipopolysaccharide. Scand J Immunol 1988;28:607-12.
114. Vermylen J, Blockmans D, Spitz B, et al. Thrombosis and immune disorder. Clin Haemtol 1986;15:393-412.
115. Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 1994;96:3-9.
116. Waddell CC, Brown JA. The lupus anticoagulant in 14 male patients. JAMA 1982;248:2493-5.
117. Wassermann A. Über die Entwicklung und den gegenwärtigen Stand der Serodiagnostik gegenüber Syphilis. Berl Klin Wochenschr 1907;44:1599.
118. Wittkowsky AK, Kino KJ. Heparin monitoring in acute thrombosis associated with antiphospholipid antibody syndrome. Pharmacotherapy 1995;15:517-21.
119. Zarrabi M, Zucker S, Miller F. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med 1979;91:194-9.
120. Zelger B, Sepp N, Stockhammer G, et al. Sneddon's syndrome. A long-term follow-up of 21 patients. Arch Dermatol 1993;129:437-47.